Skip to main content
HairCited

Acidi grassi Omega-3 per Telogen effluvium

B

Basato su 11 studi con 317 partecipanti totali. 8/11 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Moderate evidence suggests that omega-3 fatty acids may help support hair recovery in telogen effluvium, though the research base is limited and they are usually studied alongside other nutrients.

  • 8 out of 11 studies show positive effects, but total sample size is small (317 participants)
  • Often studied as part of multi-nutrient supplement formulations
  • No large-scale RCTs specifically for omega-3 and telogen effluvium
  • May support recovery through anti-inflammatory and nutritional mechanisms

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Effetto: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
narrative review
Herbal Remedies for Hair Loss: A Review of Efficacy and Safety.
Dose: varies by remedy and study vs: Placebo Effetto: None None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Effetto: None None
review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Effetto: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
Cohort n=200 Open-label
Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life …
Dose: high dose elemental iron (dose unspecified) vs: Placebo Effetto: Patients with baseline ferritin ≥50 ng/ml mostly 'very satisfied'; patients with ferritin <50 ng/ml None

Key Statistics

11

Studi

317

Partecipanti

Positive

B

Grado

Referenced Papers

Skin appendage disorders 2025 7 citazioni
Acta dermatovenerologica Croatica … 2016 6 citazioni
Therapeutische Umschau. Revue … 2002 4 citazioni
Dermatologic clinics 1993 38 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
250-500 mg EPA+DHA/day
hairloss:
1,000-2,000 mg/day

Limite massimo: 3,000 mg/day EPA+DHA

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
varies by remedy and study -- Positive --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
high dose elemental iron (dose unspecified) -- Positive 200
None -- Positive --
None -- Neutral 100
psychiatric and dermatological management -- Neutral 1

Momento migliore per l'assunzione: With meals containing fat for optimal absorption; split doses if over 1,000 mg

Safety & Side Effects

Effetti collaterali segnalati

  • Fishy aftertaste or burping
  • Mild gastrointestinal upset (nausea, diarrhea)
  • Possible increased bleeding time at high doses
  • Unpleasant body odor at very high doses

Interazioni note

  • Anticoagulants (warfarin) and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (reduces omega-3 absorption)

Livello di assunzione massimo tollerabile: 3,000 mg/day EPA+DHA

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Acidi grassi Omega-3 help with Telogen effluvium?
Based on 11 studies with 317 participants, there is moderate evidence from clinical studies that Acidi grassi Omega-3 may support Telogen effluvium management. Our evidence grade is B (Good Evidence).
How much Acidi grassi Omega-3 should I take for Telogen effluvium?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Acidi grassi Omega-3?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal upset (nausea, diarrhea), Possible increased bleeding time at high doses, Unpleasant body odor at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Acidi grassi Omega-3 and Telogen effluvium?
We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 317 total participants. The overall direction of effect is positive.

Related Evidence

Acidi grassi Omega-3 per altre condizioni

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.